High materiality9/10
Vaxcyte (PCVX) PT Raised to $125 at Guggenheim
Why it may matterVerify against the original reporting
Upside potential reinforced by high PT.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises the price target for Vaxcyte to $125 from the prior level; current price is $56.48.
- Guggenheim raises PT to $125; current price $56.48.
Key facts
- 01
Target: $125
- 02
Posted price: $56.48
- 03
Analyst firm: Guggenheim
- 04
Analyst: Seamus Fernandez
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.